Simpson Thacher represented J.P. Morgan Securities LLC and the other initial purchasers in connection with a 144A/Regulation S offering by Charles River Laboratories International, Inc. (“Charles River”) of $500 million aggregate principal amount of 4.25% Senior Notes due 2028 (the “notes”). Charles River intends to use the net proceeds from the offering of the notes, together with cash on hand, to repay a portion of the term loan facility under its senior credit facilities and to pay related fees and expenses. To date, Simpson Thacher has represented the initial purchasers in connection with $1.3 billion of debt securities issued by Charles River.
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts.
The Simpson Thacher team included Art Robinson, David Azarkh, Tony Rim, Davis Mahon and Jessica Jeong (Capital Markets); Nicole Humphrey (Tax); Andrew Blau and Caitlin Grimes (Executive Compensation and Employee Benefits); Jeanne Annarumma (ERISA); Mike Isby (Environmental); Lori Lesser and Alysha Sekhon (Intellectual Property); and Jennie Getsin (Blue Sky).